BACKGROUND AND PURPOSE: The diagnosis and treatment of breast cancer can cause considerable psychological consequences, which may remain unrecognized and untreated. In this study, the prevalence of depressive symptoms and distress, and unmet needs for psychosocial support were assessed among breast cancer patients receiving postoperative radiotherapy. MATERIAL AND METHODS: Out of 389 consecutive patients, 276 responded and comprised the final study group. Depressive symptoms were assessed with the Beck Depression Inventory. Distress was measured with the Distress Thermometer. Hospital records of the patients were examined for additional information. RESULTS: Nearly one third of patients (32.1%) displayed depressive symptoms, and more than a quarter of patients (28.4%) experienced distress. Younger age (p=0.001) and negative hormone receptor status (p=0.008) were independent factors associated with distress. One quarter of the patients expressed an unmet need for psychosocial support, which was independently associated with depressive symptoms and/or distress (p=0.001) and younger age (p=0.006). CONCLUSIONS: During radiotherapy for breast cancer, the staff should have awareness of the higher risk of depression and distress in their patients and should consider screening tools to recognise distress and depressive symptoms. Special attention should be paid to younger patients.
BACKGROUND AND PURPOSE: The diagnosis and treatment of breast cancer can cause considerable psychological consequences, which may remain unrecognized and untreated. In this study, the prevalence of depressive symptoms and distress, and unmet needs for psychosocial support were assessed among breast cancerpatients receiving postoperative radiotherapy. MATERIAL AND METHODS: Out of 389 consecutive patients, 276 responded and comprised the final study group. Depressive symptoms were assessed with the Beck Depression Inventory. Distress was measured with the Distress Thermometer. Hospital records of the patients were examined for additional information. RESULTS: Nearly one third of patients (32.1%) displayed depressive symptoms, and more than a quarter of patients (28.4%) experienced distress. Younger age (p=0.001) and negative hormone receptor status (p=0.008) were independent factors associated with distress. One quarter of the patients expressed an unmet need for psychosocial support, which was independently associated with depressive symptoms and/or distress (p=0.001) and younger age (p=0.006). CONCLUSIONS: During radiotherapy for breast cancer, the staff should have awareness of the higher risk of depression and distress in their patients and should consider screening tools to recognise distress and depressive symptoms. Special attention should be paid to younger patients.
Authors: Joanne Lester; Kara Crosthwaite; Robin Stout; Rachel N Jones; Christopher Holloman; Charles Shapiro; Barbara L Andersen Journal: Oncol Nurs Forum Date: 2015-01 Impact factor: 2.172
Authors: Mylin A Torres; Thaddeus W Pace; Tian Liu; Jennifer C Felger; Donna Mister; Gregory H Doho; Jordan N Kohn; Andrea M Barsevick; Qi Long; Andrew H Miller Journal: Cancer Date: 2013-03-19 Impact factor: 6.860
Authors: Lise Vilstrup Holm; Dorte Gilså Hansen; Christoffer Johansen; Peter Vedsted; Pia Veldt Larsen; Jakob Kragstrup; Jens Søndergaard Journal: Support Care Cancer Date: 2012-03-14 Impact factor: 3.603